US 11427838
Materials and methods for treatment of myotonic dystrophy type 1 (DM1) and other related disorders
granted A61KA61K35/34A61K38/465
Quick answer
US patent 11427838 (Materials and methods for treatment of myotonic dystrophy type 1 (DM1) and other related disorders) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K35/34, A61K38/465